★★★★★
★★★★★
Verified Buyer
Appropriate packaging and good product.
Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
99% Purity Guaranteed
Research Use Only
Secure Checkout
Oxiracetam – Powder, 50 grams
Oxiracetam is a hydroxylated pyrrolidinone derivative within the racetam structural class, distinguished from piracetam by a 4-hydroxy substitution on the pyrrolidinone ring.
Same Trusted Formula. Fresh New Look.
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly the same as per our standards.
Accepted Payment Methods
- Credit card
- Bank transfer (instant SEPA)
- Bank transfer (ACH)
- Wise
- Revolut
- Zelle
- Remitly
- Western Union
- Chime
- Others
-25% on everything – until October 31
25% off regular prices, replacing other product sales. Only the crypto payment discount can be combined.
Oxiracetam is a hydroxylated pyrrolidinone derivative within the racetam structural class, distinguished from piracetam by a 4-hydroxy substitution on the pyrrolidinone ring. Research interest centers on its proposed effects on glutamatergic AMPA receptor signalling and cholinergic pathway modulation in neuronal models.
Research applications include racetam structure-activity relationship studies, AMPA receptor pharmacology, and comparative pyrrolidinone-class compound research.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C6H10N2O3 |
|---|---|
| Synonyms | oxiracetam 62613-82-5, 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide, 4-Hydroxy-2-oxopyrrolidine-N-acetamide, ISF 2522 |
| Molar Mass | 158.16 g/mol |
| CAS Number | 62613-82-5 |
| PubChem CID | 4626 |
| Total Compound Content | 50 grams |
| Shelf Life | 36 months |
Oxiracetam is studied within the racetam family for its hydroxyl-substituted pyrrolidinone structure, a modification relative to the parent compound piracetam that is investigated for altered pharmacological profile. Proposed mechanisms under research include modulation of glutamatergic transmission via AMPA-type ionotropic glutamate receptors and influence on high-affinity choline uptake in cholinergic synaptic models, positioning oxiracetam as a tool compound for dissecting overlapping glutamatergic and cholinergic contributions to racetam-class pharmacology. Comparative electrophysiology and receptor-binding studies are used to characterise oxiracetam's relative potency against other racetam-family compounds at these targets. Independently third-party HPLC-tested; COA available per batch.
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
How does oxiracetam's structural modification relative to piracetam relate to its proposed mechanism of action?
Oxiracetam differs from piracetam by a hydroxyl group at the 4-position of the shared pyrrolidinone ring.
This structural modification is studied for its influence on receptor-binding affinity and pharmacokinetic properties relative to the parent compound, within structure-activity relationship research mapping how substitutions on the racetam core scaffold alter target engagement at glutamatergic and cholinergic systems.
Comparative binding and functional assays against piracetam and other racetam-family compounds are the standard approach for characterising this relationship.
What electrophysiological methods are used to study oxiracetam's effects on AMPA receptor signaling?
Patch-clamp electrophysiology in cultured neurons or brain slice preparations is the standard method for characterising compound effects on AMPA receptor-mediated excitatory postsynaptic currents (EPSCs), allowing researchers to quantify changes in current amplitude, kinetics, or desensitization properties following oxiracetam exposure. These functional electrophysiological readouts are typically paired with receptor-binding assays to distinguish direct receptor modulation from indirect effects on presynaptic glutamate release.
What is the research rationale for studying oxiracetam's combined effects on cholinergic and glutamatergic systems?
Because oxiracetam has been investigated for activity at both glutamatergic AMPA receptors and cholinergic high-affinity choline uptake, it serves as a research tool for studying potential crosstalk or convergent downstream effects between these two neurotransmitter systems on cognitive-relevant cellular endpoints (such as long-term potentiation models). Researchers isolating which pathway drives a given experimental outcome typically use selective antagonists for one system (e.g. an AMPA receptor antagonist) while measuring oxiracetam's effects on the other, to determine pathway dependence.
Customer Reviews (4)
★★★★★
★★★★★
4.75 / 5
★★★★★
★★★★★
Verified Buyer
Amazing products and fast shipping. I’m very happy with my purchase.
★★★★★
★★★★★
Verified Buyer
Our research results have been outstanding. I'm very happy with the super fast shipping, it's an exceptionally pure batch. Thanks for the outstanding support!
★★★★★
★★★★★
Verified Buyer
We got fantastic research results. Great quality on the service. In addition, happy with the quality of this compound. A trustworthy supplier.
